SCHEMBL5533205

SCHEMBL5533205

Cc1ccc(OC(CC(C)N)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 3/20 0.46
SLC7A5 Q01650 5/20 0.45
SLC6A4 P31645 7/20 0.44
HTR1A P08908 1/20 0.43
SLC6A2 P23975 2/20 0.42
SLC6A3 Q01959 2/20 0.42
KCNK2 O95069 1/20 0.42
KCNH2 Q12809 1/20 0.42
CACNA1C Q13936 1/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049659 0.90 SLC6A4 (0.53) SLC7A5SLC6A4SLC6A2SLC6A3KCNK2
SCHEMBL5530174 0.83 SLC6A4 (0.43) SLC6A4SLC6A2SLC6A3NPSR1
Oxalic Acid SCHEMBL7315983 0.83 SLC6A4 (0.46) SLC6A9SLC7A5SLC6A4MEN1KMT2A
SCHEMBL13050367 0.82 SLC6A4 (0.66) SLC6A9SLC7A5SLC6A4SLC6A2SLC6A3
SCHEMBL4734874 0.82 SLC6A4 (0.66) SLC6A9SLC7A5SLC6A4SLC6A2SLC6A3
SCHEMBL13050366 0.82 SLC6A4 (0.66) SLC6A9SLC7A5SLC6A4SLC6A2SLC6A3
SCHEMBL5394251 0.81 HTR2A (0.45) SLC7A5SLC6A4SLC6A2SLC6A3KCNH2
Hydrochloric Acid SCHEMBL4777538 0.81 SLC6A4 (0.64) SLC6A9SLC7A5SLC6A4SLC6A2SLC6A3
SCHEMBL7053972 0.80 SLC6A4 (0.49) SLC6A9SLC7A5SLC6A4HTR1A
SCHEMBL7310728 0.80 SLC6A9 (0.49) SLC6A9SLC6A4HTR1ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761478-A2 AN ISOLATED ATOMOXETINE IMPURITY, PROCESSES FOR THE PREPARATION OF ATOMOXETINE IMPURITIES AND THEIR USE AS REFERENCE STANDARDS Teva Pharmaceutical Fine Chemicals S.R.L. (IT) 2007-03-14 EP disclosed
WO-2006004979-A2 AN ISOLATED ATOMOXETINE IMPURITY, PROCESSES FOR THE PREPARATION OF ATOMOXETINE IMPURITIES AND THEIR USE AS REFERENCE STANDARDS TEVA PHARMACEUTICAL FINE CHEMICALS S.R.L. (IT) 2006-01-12 WO disclosed